Skip to content
Government Federal, Medical Health Aged Care

National Medicines Symposium 2025: Quality use of medicines in diabetes care

ACSQHC 3 mins read

17 October 2025

Diabetes is one of Australia’s most pressing and complex health challenges, affecting more than 1.5 million people and contributing to long-term complications, hospitalisations and premature deaths.

The National Medicines Symposium 2025, hosted by the Australian Commission on Safety and Quality in Health Care, will explore this issue under the theme ‘Quality use of medicines in people with diabetes’.

This free virtual event, on Wednesday 22 October 2025, will bring together national and international experts, clinicians, researchers, Aboriginal and Torres Strait Islander health practitioners, and people with lived experience, to explore how quality use of medicines, non-pharmacological care and emerging technologies can transform diabetes care.

More than 20 expert speakers will explore:

  • medicines management in type 1 and type 2 diabetes
  • person-centred prescribing and deprescribing
  • the importance of care at different life stages, including pregnancy, adolescence and ageing
  • equity and access to culturally safe care
  • integrated care models, including pharmacists embedded in primary care and the Diabetes Alliance Program Plus (DAP+)
  • the importance of self-management and non-pharmacological strategies such as nutrition, movement and mental health.

Chronic conditions, including diabetes, are an underlying or associated cause of 90% of all deaths in Australia. People with diabetes also face a higher risk of sepsis and complications, making safe and appropriate diabetes medicines use critical.

Associate Professor Liz Marles, Clinical Director for the Commission and a general practitioner, said medicines for diabetes must be tailored to the individual.

“Quality use of medicines in diabetes is not just about the correct prescription. It is about safe, effective, person-centred care that adapts to an individual’s life stage, cultural needs, and health priorities. This Symposium is an opportunity to drive national conversations and practical action to improve care for every person living with diabetes,” said Associate Professor Marles.

Professor Andrew McLachlan, Head of School and Dean of Pharmacy at the University of Sydney, and Symposium facilitator, highlighted the importance of collaboration and innovation.

"Emerging medicines, technology, and care models present new opportunities to improve outcomes for people with diabetes. The Symposium will showcase how clinicians, researchers and consumers can work together to advance safe and effective diabetes management."

Key speakers include:

  • Distinguished Professor David Simmons, Chief Medical Officer for Diabetes Australia, Professor of Medicine at Western Sydney University and District Advisor on Diabetes for the South Western Sydney Local Health District
  • Professor Jennifer Martin, Physician, Clinical Pharmacologist and President of the Royal Australasian College of Physicians
  • Professor Jonathan Shaw, Deputy Director of Clinical and Population Health, Baker Heart and Diabetes Institute
  • Professor Stephen Twigg, Head of Endocrinology, Royal Prince Alfred Hospital and Kellion Professor of Endocrinology, Stan Clark Chair in Diabetes and Head of Central Clinical School, The University of Sydney.
  • Professor Shamasunder Acharya, Director of Diabetes and Endocrinology and Program Lead for Diabetes Alliance Plus, Hunter New England Health District
  • Ms Sarah Lam, Senior Clinical Psychologist, Bankstown Hospital Diabetes Centre.

Register now

Don’t miss this opportunity to hear from Australia’s leading experts in diabetes care and medicines safety. Register today for the National Medicines Symposium 2025 and join the national conversation on how to improve quality use of medicines in people with diabetes.

 

Date: 22 October 2025

Time: 9:00 am – 3:30 pm AEDT

Format: Free, virtual event

Register now: safetyandquality.tv/NMS25

 

 

About the Commission

The Australian Commission on Safety and Quality in Health Care leads and coordinates national improvements in the safety and quality of health care based on the best available evidence. By working in partnership with patients, carers, clinicians, the Australian, state and territory health systems, the private sector, managers and healthcare organisations, the Commission aims to ensure that the health system is better informed, supported and organised to deliver safe and high-quality care. safetyandquality.gov.au

 

Media enquiries

Michelle Boland, Senior Communications Officer

E: [email protected]

Media

More from this category

  • Government Federal, Union
  • 19/11/2025
  • 14:01
Health Services Union

Union questions charities watchdog over hospital giant’s not-for-profit status

The Health Services Union (HSU) has raised serious concerns over Healthscope, a for-profit company with $1.6 billion in debt, being granted charitable status to exploit tax concessions worth $200 million annually. In a letter to Australian Charities and Not-for-profits Commission ACNC Commissioner Sue Woodward, ATO Commissioner Rob Heferen, and Assistant Minister Andrew Leigh, the union has warned Healthscope's charitable status may breach ACNC governance standards and questioned how such a decision could be made. "How does a private company drowning in $1.6 billion of debt and backed by one trillion dollars in assets suddenly become a charity? This makes a…

  • Medical Health Aged Care
  • 19/11/2025
  • 12:14
Australian Cardiovascular Alliance

National Hypertension Taskforce recommends potassium-enriched salt to lower blood pressure

The National Hypertension Taskforce of Australia has published a new position statement in the Journal of Hypertension, recommending that potassium-enriched salt be incorporated into Australia’s hypertension management guidelines as a safe, effective, and scalable strategy to help lower blood pressure and reduce cardiovascular disease. The National Hypertension Taskforce is a joint initiative of the Australian Cardiovascular Alliance and Hypertension Australia, which has set the goal of increasing Australia’s controlled blood pressure from 32% to 70% by 2030. The Taskforce has 25 members across the health spectrum including peak bodies, professional societies, clinicians, researchers and consumers with lived experience. The statement,…

  • Medical Health Aged Care
  • 19/11/2025
  • 11:33
Royal Australian College of GPs

‘This is another key step forward in saving lives’: GPs back Victorian Government drug testing expansion

GPs are throwing their support behind a Victorian Government plan to expand drug testing across the state, including at major music festival events late this year and in 2026. The Victorian Mental Health Minister, the Hon Ingrid Stitt, has committed to lifesaving drug testing sites being available at events including “Spilt Milk” on 6 December, “Dangerous Goods 6XXL” on 24 January and the “Pitch Music and Arts Festival” on 6–10 March next year, with further events to be announced soon. Earlier this year, the Royal Australian College of GPs (RACGP) strongly endorsed the state Government opening Victoria’s first ever fixed…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.